Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Tonic Clonic Seizure”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Post-approval studies (Phase 4)Study completedNCT00266604
What this trial is testing

Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Who this might be right for
EpilepsySeizuresEpilepsies, Partial+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Not applicableLooking for participantsNCT06657378
What this trial is testing

Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Who this might be right for
Partial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 110
Not applicableStudy completedNCT02736162
What this trial is testing

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

Who this might be right for
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 61
Large-scale testing (Phase 3)Ended earlyNCT03299842
What this trial is testing

Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 5
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Large-scale testing (Phase 3)Looking for participantsNCT06579573
What this trial is testing

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Who this might be right for
Epilepsy, Generalized
Ono Pharmaceutical Co., Ltd. 15
Large-scale testing (Phase 3)Study completedNCT01243177
What this trial is testing

Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older

Who this might be right for
EpilepsyMonotherapy
UCB BIOSCIENCES GmbH 888
Not applicableStudy completedNCT05147571
What this trial is testing

RNS System NAUTILUS Study

Who this might be right for
EpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure
NeuroPace 100
Testing effectiveness (Phase 2)Study completedNCT01118949
What this trial is testing

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 49
Large-scale testing (Phase 3)Ended earlyNCT06425159
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Who this might be right for
Generalized Epilepsy
Biohaven Therapeutics Ltd. 27
Large-scale testing (Phase 3)Study completedNCT01292837
What this trial is testing

Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsyGeneralized Tonic-clonic Seizures
UCB Japan Co. Ltd. 13
Not applicableStudy completedNCT04770337
What this trial is testing

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory EpilepsyFocal SeizureSeizures, Focal+4 more
Neuroelectrics Corporation 127
Large-scale testing (Phase 3)Study completedNCT01228747
What this trial is testing

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Who this might be right for
EpilepsyGeneralized Tonic-Clonic Seizures
UCB Japan Co. Ltd. 361
Large-scale testing (Phase 3)Study completedNCT02849626
What this trial is testing

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

Who this might be right for
Partial-Onset or Primary Generalized Tonic-Clonic Seizures
Eisai Inc. 180
Large-scale testing (Phase 3)Study completedNCT00236886
What this trial is testing

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Who this might be right for
EpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 49
Post-approval studies (Phase 4)Study completedNCT00510783
What this trial is testing

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Who this might be right for
Tonic-clonic Seizure
Emory University 158
Not applicableNo Longer AvailableNCT02307578
What this trial is testing

An Extended Access Program (EAP) for Perampanel

Who this might be right for
Primary Generalized Tonic-Clonic or Partial Onset SeizuresLennox Gastaut Syndrome
Eisai Inc.
Large-scale testing (Phase 3)Study completedNCT02408523
What this trial is testing

Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 242
Not applicableStudy completedNCT02722590
What this trial is testing

Fycompa (Perampanel) in Korean Participants

Who this might be right for
Epilepsy
Eisai Korea Inc. 3,692
Next Page